Study Shows CLn BodyWash Helps People With Hidradenitis Suppurativa (HS) Improve Comfort and Confidence
Clinical Study Led by HS Connect Demonstrates Significant Reduction in HS Symptoms and Improved Quality of Life With Daily Use...
Pharmaceutical
Study Shows CLn BodyWash Helps People With Hidradenitis Suppurativa (HS) Improve Comfort and Confidence
Clinical Study Led by HS Connect Demonstrates Significant Reduction in HS Symptoms and Improved Quality of Life With Daily Use...
Tenon Medical(R) Announces FDA 510(k) Clearance for SImmetry(R)+ SI Joint Fusion System
~Clearance expands Company's competitive advantage of clinically proven, minimally invasive technologies to treat debilitating SI joint conditions from multiple surgical...
Tenon Medical(R) Announces FDA 510(k) Clearance for SImmetry(R)+ SI Joint Fusion System
~Clearance expands Company's competitive advantage of clinically proven, minimally invasive technologies to treat debilitating SI joint conditions from multiple surgical...
VSee Health (Nasdaq:VSEE) Secures Game-Changing 10M+ Teleradiology Contract, Igniting Explosive Growth in Booming Telehealth Sector
VSee multi-year teleradiology contract with a major level 1 hospital is set to double annual recurring revenue and pave the...
VSee Health (Nasdaq:VSEE) Secures Game-Changing 10M+ Teleradiology Contract, Igniting Explosive Growth in Booming Telehealth Sector
VSee multi-year teleradiology contract with a major level 1 hospital is set to double annual recurring revenue and pave the...
Investors at a Crossroads: Remote Monitoring, Wellness Apps, and Oversold Health IT Categories Face a 2025 Funding Recession as ROI Fatigue Sets In
Investor sentiment is cooling sharply across once-hot digital health sectors. LAS VEGAS, NV / ACCESS Newswire / October 21, 2025...
Investors at a Crossroads: Remote Monitoring, Wellness Apps, and Oversold Health IT Categories Face a 2025 Funding Recession as ROI Fatigue Sets In
Investor sentiment is cooling sharply across once-hot digital health sectors. LAS VEGAS, NV / ACCESS Newswire / October 21, 2025...
CellRight Technologies, LLC Announces Update and Senior Leadership Changes
CellRight announces Senior leadership changes, implementation of new commercial plan and cost reduction initiatives SAN ANTONIO, TX / ACCESS Newswire...
CellRight Technologies, LLC Announces Update and Senior Leadership Changes
CellRight announces Senior leadership changes, implementation of new commercial plan and cost reduction initiatives SAN ANTONIO, TX / ACCESS Newswire...
Telomir Pharmaceuticals Executes Binding LOI for Worldwide Rights to Telomir-1, Positioning the Company for Global Market Expansion and Value Growth
Unifying global IP rights and enabling up to $5 million in potential shareholder contributions, the agreement strengthens Telomir's foundation for...
Telomir Pharmaceuticals Executes Binding LOI for Worldwide Rights to Telomir-1, Positioning the Company for Global Market Expansion and Value Growth
Unifying global IP rights and enabling up to $5 million in potential shareholder contributions, the agreement strengthens Telomir's foundation for...
AIML Subsidiary NeuralCloud Solutions Commencing Pilot with Canadian Cardiology Clinic to Advance AI-Powered ECG Reporting
NeuralCloud Solutions to deploy its CardioYield™ platform in a multi-stage pilot program with a full-service cardiology clinic in Canada.Enhance Holter...
CBD Life Sciences Inc. (CBDL) Launches First-of-Its-Kind Mushroom-Infused “Dubai Chocolate Bar”
Dubai's luxury chocolate market-valued at over $1.5 billion and growing 6.8% annually-meets the $35 billion global mushroom supplement boom, creating...
Recordati Launches 12th Edition of Arrigo Recordati Prize to Support Research in Paediatric Oncology
The 2026 Award is focused on research in paediatric oncology, specifically sarcomasPaediatric sarcomas are among the leading causes of cancer-related...
Nexalin’s DIFS™ Neurostimulation Shows Cognitive and Brain Network Improvements in Alzheimer’s and Dementia Across Three Peer-Reviewed Studies
Three Independent Studies Published in “Alzheimer’s Research & Therapy,” “Journal of Alzheimer’s Disease,” and “Radiology” Validate Nexalin’s Non-Invasive Approach with...
Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics’ Global Phase 3 Trials of Dotinurad for the Treatment of Gout
MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Urica Therapeutics, Inc. (“Urica” or the “Company”), a Fortress Biotech, Inc. (Nasdaq: FBIO)...
Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025
BRISBANE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical...
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL®
BRISBANE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to...
Quoin Pharmaceuticals Announces U.S. FDA Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
Upon Approval of NDA Quoin Will Receive Seven Years Marketing Exclusivity for QRX003 in the US Orphan Drug Designation previously...